Back to search

Article

Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals

2024-02-09

Abstract excerpt

<h4>SUMMARY</h4> Immunization with mosaic-8b [60-mer nanoparticles presenting 8 SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs)] elicits more broadly cross-reactive antibodies than homotypic SARS-CoV-2 RBD-only nanoparticles and protects against sarbecoviruses. To investigate original antigenic sin (OAS) effects on mosaic-8b efficacy, we evaluated effects of prior COVID-19 vaccinations in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
023a1e13-88eb-5b58-9e23-33110513bd1f
DOI
10.1101/2024.02.08.576722
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animalsDOI 10.1101/2024.02.08.576722
Select a neighboring publication to make it the new centre.